PSY95 - EXPLORING THE POTENTIAL COST-EFFECTIVENESS OF EMICIZUMAB FOR HEMOPHILIA A WITH INHIBITOR IN ITALY
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2670
https://www.valueinhealthjournal.com/article/S1098-3015(18)35972-2/fulltext
Section Title :
Section Order :
2024
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35972-2&doi=10.1016/j.jval.2018.09.2670